نتائج البحث

Disease–Drug–Drug Interaction of Imatinib in COVID‐19 ARDS: A Pooled Population Pharmacokinetic Analysis.

• Authors : Said, Medhat M.^1,2 (AUTHOR) ; Schippers, Job R.^3,4 (AUTHOR); Atmowihardjo, Leila^5,6 (AUTHOR)

• Source: CPT: Pharmacometrics & Systems Pharmacology. Mar2025, Vol. 14 Issue 3, p583-595. 13p.

تفاصيل العنوان

A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined with Atezolizumab Versus Imatinib Resumption Alone in Patients with Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments (ATEZOGIST)

• Source: A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined with Atezolizumab Versus

تفاصيل العنوان

Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator

• Source: An Open Label, Multi-center Imatinib Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Imatinib Study and

تفاصيل العنوان

پیشگویی تمایل اتصال تعدادی از مشتقات ایماتینیب به عنوان مهار کننده های تیروزین کیناز بر اساس بهینه سازی مونت کارلو.

• Authors : شهرام لطفی¹; شهین احمدی² ; شراره وردست باغم³

Subjects: *THERAPEUTIC use of antineoplastic agents; *STATISTICAL correlation; *HEMATOLOGIC malignanciesIRAN

• Source: Journal of Ilam University of Medical Sciences. 2024, Vol. 32 Issue 4, p66-86. 21p.

تفاصيل العنوان

Assessment of Imatinib Anti-Remodeling Activity on a Human Precision Cut Lung Slices Model.

• Authors : Bozzini, Sara¹ (AUTHOR) ; Bozza, Eleonora² (AUTHOR); Bagnera, Cecilia² (AUTHOR)

Subjects: *PROTEIN-tyrosine kinase inhibitors; *PULMONARY fibrosis; *EPITHELIAL cells

• Source: International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 15, p8186. 12p.

تفاصيل العنوان

Stretching the structural envelope of imatinib to reduce β-amyloid production by modulating both β- and γ-secretase cleavages of APP.

• Authors : Netzer, William J.¹ ; Sinha, Anjana¹ ; Ghias, Mondana¹

• Source: Frontiers in Chemistry. 2024, p1-40. 40p.

تفاصيل العنوان

Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study

• Authors : Hompland, I; Boye, K; Wiedswang, AM

Subjects: Medicin och hälsovetenskap

• Source: Acta oncologica (Stockholm, Sweden). 63:288-293

تفاصيل العنوان

SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activation.

• Authors : Zhang L; School of Basic Medical Sciences, Ningxia Medical University, Shengli Street 1160, Yinchuan, 750004, China.; Xiao K

Subjects: Proto-Oncogene Proteins c-kit*/Proto-Oncogene Proteins c-kit*/Proto-Oncogene Proteins c-kit*/metabolism ; Proto-Oncogene Proteins c-kit*/Proto-Oncogene Proteins c-kit*/Proto-Oncogene Proteins c-kit*/genetics ; Gastrointestinal Stromal Tumors*/Gastrointestinal Stromal Tumors*/Gastrointestinal Stromal Tumors*/metabolism

• Source: Scientific reports [Sci Rep] 2025 Feb 08; Vol. 15 (1), pp. 4779. Date of Electronic Publication: 2025 Feb 08.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

The interplay of knowledge, motivation, and treatment response in medication adherence among patients with chronic myeloid leukemia treated with Imatinib.

• Authors : Omran MM; Cancer Biology Department, Pharmacology Unit, National Cancer Institute, Cairo University, Cairo, Egypt.; Ibrahim AB

Subjects: Imatinib Mesylate*/Imatinib Mesylate*/Imatinib Mesylate*/therapeutic use ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/psychology

• Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Jan; Vol. 66 (1), pp. 123-130. Date of Electronic Publication: 2024 Sep 18.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

A Study of Pimitespib in Combination with Imatinib in Patients with GIST (CHAPTER-GIST-101)

• Source: A Phase 1 Study of TAS-116 (pimitespib) in Combination with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumor

تفاصيل العنوان